Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Cardiology/Vascular Diseases | Genetic Disease | Family Medicine
Coronary Artery Disease Clinical Trials
A listing of Coronary Artery Disease medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : Cardiology PC
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Birmingham : University of Alabama at Birmingham
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Birmingham : Cardiology, PC
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Birmingham : University of Alabama at Birmingham
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Birmingham : University Hospital - Univ. of Alabama at Birmingham (UAB)
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
View More »
Birmingham : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Huntsville : Huntsville Hospital - The Heart Center, PC Updated
PROMUS Element Plus US Post-Approval Study
Huntsville : Heart Center Research, LLC
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Huntsville : Heart Center Research, LLC
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Huntsville : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Mobile : Cardiology Associates of Mobile, Inc.
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Alaska
Anchorage : Alaska Heart Institute
PRE-DETERMINE Cohort Study
Anchorage : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Little Rock : Arkansas Heart Hospital
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Arizona
Gilbert : Mercy Gilbert Medical Center
An Observational Study of Cholesterol in Coronary Arteries
Gilbert : Mercy Gilbert Medical Center
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Gilbert : Arizona Sun Family Medicine
Investigation of a Novel Gene Expression Test for the Diagnosis of Obstructive Coronary Artery Disease on Physician's Practice Pattern
Glendale : Phoenix Heart, PLLC
PRE-DETERMINE Cohort Study
Meza : Banner Heart Hospital
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
View More »
Phoenix : Arizona Heart Institute Ltd.
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Phoenix : Mayo Clinic Hospital, Cardiac Cath Lab
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Phoenix : Cardiovascular Consultants
PRE-DETERMINE Cohort Study
Scottsdale : Scottsdale Medical Imaging, Ltd.
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Scottsdale : Scottsdale Healthcare
An Observational Study of Cholesterol in Coronary Arteries
Scottsdale : Scottsdale Healthcare Shea
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
Scottsdale : Scottsdale Healthcare Osborn Campus
Evaluation of Patients in Chest Pain in the Emergency Room
Scottsdale : Scottsdale Healthcare Shea Campus
Evaluation of Patients in Chest Pain in the Emergency Room
Scottsdale : Scottsdale Healthcare
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Tempe : Fiel Family Medicine
Investigation of a Novel Gene Expression Test for the Diagnosis of Obstructive Coronary Artery Disease on Physician's Practice Pattern
Arkansas
California
Santa Ana : Coastal Multi-Specialty Research
TAKEDA EXAMINE trial patients for who have Type II diabetes & ACS coronary artery disease, post angiogram or heart attack. This is a phase 3b study. Currently open for enrollment.
View More »
Beverly Hills : West Side Medical Associates of Los Angeles
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Concord : John Muir Medical Center
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Concord : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Fullerton : St. Jude Hospital
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Glendale : Glendale Memorial Hospital and Medical Center
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
La Jolla : Scripps Clinic
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
La Jolla : University of California San Diego
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
La Jolla : Scripps Memorial Hospital La Jolla
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Lajolla : Research Site
A Pharmacodynamic Study With Ticagrelor in Hispanic Patients
Loma Linda : Loma Linda University Medical Center Updated
PROMUS Element Plus US Post-Approval Study
Lomita : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Los Angeles : Research Site
A Pharmacodynamic Study With Ticagrelor in Hispanic Patients
Los Angeles : Cedars-Sinai Medical Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Los Angeles : UCLA
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Los Angeles : USC PET Imaging Science Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Los Angeles : VA West Los Angeles Medical Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Los Angeles : University of California, Los Angeles Medical Center
An Observational Study of Cholesterol in Coronary Arteries
Los Angeles : David Geffen School of Medicine at UCLA
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Los Angeles : Cedars-Sinai Medical Center
Low Dose One-Day Tc99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera For Detection of Coronary Disease
Los Angeles : University of Southern California
Same Day Discharge After Coronary Stenting Trial
Los Angeles : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Los Angeles : University of Southern California
Using Magnetic Resonance Imaging to Evaluate Carotid Artery Plaque Composition in People Receiving Cholesterol-Lowering Medications (The CPC Study)
Madera : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Mission Viejo :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Mission Viejo : Mission Internal Medical Group
Evaluation Using ClearView in Determining Association to the Cardiac Risk Factors
Moreno Valley : Spectrum Clinical Research Institute, Inc
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Northridge : Cardiac Rhythm Specialists, Inc.
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Oakland : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Orange : University of California Irvine Medical Center
An Observational Study of Cholesterol in Coronary Arteries
Oxnard : St. John's Regional Medical Center, Catholic Healthcare West
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Palo Alto : Veterans Affairs Palo Alto Health Care System
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Pasadena : Novartis Investigative Site
Efficacy of LCQ908 on Cardiovascular Risk
Pleasant Hill : Cardiovascular Consultants Medical Group
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Poway : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Sacramento : Northern California PET Imaging Center-Palo Alto
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Sacramento : Sutter Heart and Vascular Institute
LifeVest Post-CABG Registry
Sacramento : Mercy Heart and Vascular Institue
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Sacramento : Mercy General Hospital Updated
PROMUS Element Plus US Post-Approval Study
Sacramento : Sutter Memorial Hospital
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Sacramento : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
San Diego : VA San Diego Healthcare System
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
San Diego : University of California, San Diego
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
San Diego : Veterans Affairs San Diego Healthcare System
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
San Diego : Alvarado Hospital Medical Center
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
San Diego : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
San Francisco : UCSF Medical Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
San Francisco : San Francisco Veterans Affairs Medical Center
An Observational Study of Cholesterol in Coronary Arteries
San Francisco : San Francisco Veterans Affairs Medical Center
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
San Francisco : San Francisco Veterans Affairs Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
San Ramon : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Santa Ana : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Santa Clara : Abbott Vascular
A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System
Santa Clara : Abbott Vascular
EXCEL Clinical Trial
Santa Clara : Abbott Vascular
EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions
Spring Valley : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Stanford : Stanford University, James Clark Center E-120
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Sylmar : OV-UCLA Medical Center
The Effect of Fish Oil Supplementation on Endothelial Function, Heart Rate Variability and Intimal Media Thickness of Patients With Coronary Artery Disease
Walnut Creek : John Muir Medical Center Concord Campus
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Westlake Village : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Colorado
Aurora :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Colorada Springs : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Colorado Springs : Pikes Peak Cardiology
PRE-DETERMINE Cohort Study
Colorado Springs : Colorado Cardiac Alliance
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Denver : Colorado Heart and Vascular
PRE-DETERMINE Cohort Study
View More »
Denver : South Federal Family Practice
Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance
Denver : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Golden : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Littleton : South Denver Cardiology Associates, PC
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Thornton : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Connecticut
Bridgeport : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Hartford : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
New Haven : Yale University
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
New Haven : Yale New Haven Hospital
Detecting Heart Disease Using First Pass Imaging With Gated SPECT Perfusion
New Haven : Yale University School of Medicine
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Delaware
Newark : Research Site
A Pharmacodynamic Study With Ticagrelor in African American Patients
Newark : Alfieri Cardiology
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Newark : Christiana Care Health System
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Newark : Christiana Hospital Updated
PROMUS Element Plus US Post-Approval Study
Newark : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
View More »
Wilmington : Research Site
A Pharmacodynamic Study With Ticagrelor in African American Patients
District of Columbia
Washington : Research Site
A Pharmacodynamic Study With Ticagrelor in African American Patients
Washington : Washington Hospital Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Washington : Washington Hospital Center
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Florida
Daytona Beach : Cardiology Research Associates
Coronary Artery Disease, de Novo Bifurcation Lesions of the Main & Side Branch Within Native Coronaries
Daytona Beach : Cardiology Research Associates
Orbital Artherectomy System in Treating Severely Calcified Coronary Lesions
Fort Lauderdale : Holy Cross Jim Moran Heart and Vascular Research Institute
ALERTS (Angel Med): Implanted device designed to continuously monitor the electrocardiogram signals and detect shifts that could indicate of a blockage of a coronary artery
Tampa : Tampa Clinical Research
Have You Experienced A Recent Heart Attack?
View More »
Atlantis : Zasa Clinical Research
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Atlantis : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Aventura : Elite Research and Clinical Trials
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Boynton Beach : Independent Imaging, LLC
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Boynton Beach : Bethesda Memorial Hospital
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Brandon : Bay Area Cardiology Associates, P.A.
PRE-DETERMINE Cohort Study
Brandon : Brandon Regional Hospital Updated
PROMUS Element Plus US Post-Approval Study
Clearwater : Coastal Cardiology Consultants dba The Heart & Vascular Institute of Florida
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Cooper City :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Daytona Beach : Cardiology Research Associates
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Daytona Beach : Cardiology Research Associates
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Fort Lauderdale : Broward General Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Fort Myers : Florida Heart Associates
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Gainesville : University of Florida, Gainesville
An Observational Study of Cholesterol in Coronary Arteries
Gainesville : University of Florida, Division of Cardiovascular Medicine
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Gainesville : University of Florida - Gainsville
PRE-DETERMINE Cohort Study
Gainesville : North Florida Regional Medical Center Updated
PROMUS Element Plus US Post-Approval Study
Gainesville : University of Florida
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Gainesville : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Hialeah : Future Care Solution, LLC
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Hialeah : Michigan Heart, PC
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Hollywood : Research Site
A Pharmacodynamic Study With Ticagrelor in African American Patients
Hollywood : Research Site
A Pharmacodynamic Study With Ticagrelor in Hispanic Patients
Hollywood : Memorial Regional Hospital Updated
PROMUS Element Plus US Post-Approval Study
Jacksonville : Research Site
A Pharmacodynamic Study With Ticagrelor in African American Patients
Jacksonville : Research Site
A Pharmacodynamic Study With Ticagrelor in Hispanic Patients
Jacksonville : St. Luke's Cardiology Associates
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Jacksonville : Mayo Clinic - Jacksonville
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Jacksonville : University of Florida, Shands Jacksonville Cardiovascular Center
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Jacksonville : Mayo Clinic Research Unit
Exercise Stress Testing on Peripheral Gene Expression Using CORUS™ CAD Diagnostic Test
Jacksonville : University of Florida
Impact of Ticagrelor Re-load on Pharmacodynamic Profiles
Jacksonville : Shands Jacksonville Medical Center
PRE-DETERMINE Cohort Study
Jacksonville : Cardiology Consultants of Northwest Florida
PRE-DETERMINE Cohort Study
Jacksonville : University of Florida - Jacksonville
PRE-DETERMINE Cohort Study
Jacksonville : Jacksonville Heart Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Jacksonville : Mayo Clinic Jacksonville
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Jacksonville : University of Florida Health Sciences Center-Jacksonville
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Jacksonville : East Coast Institute for Research
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Jacksonville : University of Florida
Regadenoson to Achieve Maximal Hyperemia for Fractional Flow Reserve in the Catheterization Lab
Jacksonville : First Coast Cardiovascular Institute
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Jacksonville : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Jacksonville Beach : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Lake Mary : The Cardiovascular Center, PA
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Lakeland : Watson Clinic Center
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Melbourne : Melbourne Cardiac Research Institute
PRE-DETERMINE Cohort Study
Miami : Research Site
A Pharmacodynamic Study With Ticagrelor in Hispanic Patients
Miami : University of Miami School of Medicine
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Miami : Reliable Clinical Research
PRE-DETERMINE Cohort Study
Miami : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Miami Beach : Mount Sinai Medical Center Updated
PROMUS Element Plus US Post-Approval Study
Miami Beach : Mount Sinai Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Ocala : Munroe Regional Medical Center
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Ocala : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Orlando : Florida Hospital/Cardiovascular Institute (Florida Heart Group)
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Orlando : Florida Hospital
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Orlando : Florida Hospital Cardiovascular Research Institute
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Orlando : Florida Hospital
PRE-DETERMINE Cohort Study
Orlando : Orlando Regional Medical Center
PRE-DETERMINE Cohort Study
Orlando : Orlando Regional Medical Center Updated
PROMUS Element Plus US Post-Approval Study
Orlando : Florida Hospital Orlando
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Palm Beach Gardens : Palm Beach Gardens Research Center
PRE-DETERMINE Cohort Study
Panama City : Bay Medical Center Updated
PROMUS Element Plus US Post-Approval Study
Panama City : Cardiovascular Institute of Northwest Florida
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Pembroke Pines : South Florida Research Solutions
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Ponte Verda : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Sarasota : Velella Research
PRE-DETERMINE Cohort Study
Stuart : Martin Memorial Health Systems - Martin Memorial Medical Center Updated
PROMUS Element Plus US Post-Approval Study
Tallahassee : Tallahassee Research Institute, Inc.
PRE-DETERMINE Cohort Study
Tallahassee : Tallahassee Research Institute
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Tallahassee : Tallahassee Research Institute, Inc.
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Tampa : Memorial Hospital of Tampa
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Tampa : Pepin Heart Hospital
An Observational Study of Cholesterol in Coronary Arteries
Tampa : Florida Hospital Pepin Heart Institute/Dr. Kiran C. Patel Research Institute
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Tampa : Pepin Heart Hospital and Dr. Kiran C. Patel Research Institute
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
West Palm Beach : Cardiology Associates of Palm Beach - West Palm Beach
PRE-DETERMINE Cohort Study
Winter Park :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Georgia
Atlanta : Research Site
A Pharmacodynamic Study With Ticagrelor in African American Patients
Atlanta : Piedmont Hospital
An Observational Study of Cholesterol in Coronary Arteries
Atlanta : Emory University Hospital
Assessment of Translesional Markers and Metabolomics
Atlanta : St. Joseph Hospital of Atlanta
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Atlanta : Saint Joseph's Health System, Inc.
LifeVest Post-CABG Registry
View More »
Atlanta : Emory University Hospital Midtown
Management of New-Onset Postoperative Atrial Fibrillation
Atlanta : Piedmont Hospital Updated
PROMUS Element Plus US Post-Approval Study
Atlanta : Emory University Hospital
RiaSTAP vs. Conventional Transfusion in Patients Having Heart Valve Surgery
Augusta : Georgia Health Sciences Univ/Med College of GA
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Conyers : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Covington : Georgia Heart Specialist
PRE-DETERMINE Cohort Study
Cumming : Atlanta Heart Specialist, LLC
Ranolazine, Ethnicity and the Metabolic Syndrome
Gainesville : Northeast Georgia Heart Center, P.C.
PRE-DETERMINE Cohort Study
Gainesville : Northeast Georgia Heart Center, PC
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Macon : Coliseum Medical Center Updated
PROMUS Element Plus US Post-Approval Study
Savannah : South Coast Imaging Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Tucker : Atlanta Heart Specialists, LLC
Ranolazine, Ethnicity and the Metabolic Syndrome
Woodstock : Town Lake Internal Medicine
Investigation of a Novel Gene Expression Test for the Diagnosis of Obstructive Coronary Artery Disease on Physician's Practice Pattern
Hawaii
Honolulu : Kaiser Foundation Hospital
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Illinois
Aurora : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Chicago : Northwestern University
Comprehensive Evaluation of Ischemic Heart Disease Using MRI
Chicago : Northwestern Memorial Hospital
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Chicago : Rush University Medical Center
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Chicago : Northwestern University
Half-Dose Radiopharmaceutical in Wide Beam Reconstruction
View More »
Chicago : Northwestern University Feinberg School of Medicine
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Chicago : Advocate Medical Group - Heart and Vascular of IL
PRE-DETERMINE Cohort Study
Chicago : University of Chicago
PRE-DETERMINE Cohort Study
Chicago : University of Chicago Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Chicago : Northwestern Memorial Hospital
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Chicago : University of Chicago
Stress Testing and Cardiac Magnetic Resonance
Chicago : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Jerseyville : Gateway Cardiology, PC
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Jerseyville : Gateway Cardiology, PC
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Melrose Park : Consultants in Cardiovascular Medicine
PRE-DETERMINE Cohort Study
Melrose Park : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Quincy : Blessing Hospital Updated
PROMUS Element Plus US Post-Approval Study
Indiana
Anderson : Community Heart and Vascular
PRE-DETERMINE Cohort Study
Avon : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Carmel : Clarian North Medical Center Updated
PROMUS Element Plus US Post-Approval Study
Fort Wayne : Northern Indiana Research Alliance
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Franklin : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
View More »
Greenfield : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Indianapolis :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Indianapolis : Indiana Heart Hospital Updated
PROMUS Element Plus US Post-Approval Study
Indianapolis : Franciscan St. Francis Hospital Updated
PROMUS Element Plus US Post-Approval Study
Indianapolis : Indiana Heart Physicians, Inc.
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Indianapolis : The Indiana Heart Hospital
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Indianapolis : St. Vincent's Medical Group, Inc.
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Indianapolis : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Valparaiso : Northwest Indiana Cardiovascular Physicians
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Valparaiso : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Iowa
Des Moines : Mercy Hospital Medical Center
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Iowa City : University of Iowa, Dept. of Cardiology
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Iowa City : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
West De Moines : Iowa Heart Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
West Des Moines : Iowa Heart Medical Center
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
View More »
West Des Moines : Iowa Heart Center
PRE-DETERMINE Cohort Study
West Des Moines : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Kansas
Kansas City : Cardiovascular Imaging Technologies
A Single Center Study to Establish the Imaging Protocol of 99mTc-EC-DG in Evaluating the Presence and Severity of Coronary Artery Disease (CAD)
Kansas City :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Kansas City : The University of Kansas
PRE-DETERMINE Cohort Study
Kansas City : Mid-America Cardiology Associates, PC
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Overland Park : Midwest Cardiology Associates
GLOBAL Clinical Study
Kentucky
Ashland : Kentucky Heart Institute / King's Daughter
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Ashland : Kings Daughters Medical Center
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Crestview Hills : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Lexington : Central Baptist Hospital
PRE-DETERMINE Cohort Study
Lexington : St. Joseph Hospital Updated
PROMUS Element Plus US Post-Approval Study
View More »
Lexington : Saint Joseph Cardiology Associates
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Lexington : Central Baptist Hospital
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Louisville : Norton Cardiovascular Associates
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Louisville : University of Louisville, Department of Anesthesiology and Perioperative Medicine
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Louisville : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Louisiana
Houma : Leonard J. Chabert Medical Center
PRE-DETERMINE Cohort Study
Lafayette : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Maringouin : Maringouin Medical Center
Investigation of a Novel Gene Expression Test for the Diagnosis of Obstructive Coronary Artery Disease on Physician's Practice Pattern
Minden : Clinical Trials of America, Inc.
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
New Iberia : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
View More »
New Orleans : Ochsner Clinic
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
New Orleans : Ochsner Medical Center
Intravenous Regadenoson Versus Intravenous Adenoscan® for Fractional Flow Reserve (FFR)
New Orleans : Interim LSU Public Hospital
PRE-DETERMINE Cohort Study
New Orleans : Ochsner Clinic Foundation
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
New Orleans : Ochsner Medical Center
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Shreveport : Biomedical Research Foundation of Northwest Louisiana
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Shreveport : Cardiovascular Research, LLC Updated
PROMUS Element Plus US Post-Approval Study
Shreveport : Clinical Trials of America, Inc.
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Simmesport : KD Health and Wellness Center
A Registry to Evaluate Patterns of Care Associated With the Use of Corus® CAD in Real World Clinical Care Settings
Slidell : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Zachary : The Bonin Clinic
Investigation of a Novel Gene Expression Test for the Diagnosis of Obstructive Coronary Artery Disease on Physician's Practice Pattern
Maine
Auburn : Maine Research Associates
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Auburn : Maine Research Associates
PRE-DETERMINE Cohort Study
Auburn : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Bangor : Eastern Maine Medical Center Updated
PROMUS Element Plus US Post-Approval Study
Bangor : Northeast Cardiology Associates
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
View More »
Bangor : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Lewiston : Maine Research Associates - Lewiston
PRE-DETERMINE Cohort Study
Scarborough : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Maryland
Baltimore : Spectrum Clinical Research, Inc.
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) - TIMI 52 (SOLID)
Baltimore : Spectrum Clinical Research, Inc.
A Safety and Efficacy Study to Evaluate the Potential of Aleglitazar to Reduce Cardiovascular Risk in Coronary Heart Disease (CHD) Patients With a Recent Acute Coronary Syndrome (ACS) Event and Type 2 Diabetes Mellitus (T2D)
View More »
Baltimore : Johns Hopkins University
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Baltimore : Sinai Center for Thrombosis Research
Multi-Analyte, Genetic, and Thrombogenic Markers of Atherosclerosis
Baltimore : University of Maryland Medical Center
PRE-DETERMINE Cohort Study
Baltimore : Union Memorial Hospital
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Baltimore : MedStar Research Institute
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Baltimore : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Oxon Hill : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Takoma Park : Washington Adventist Hospital
An Observational Study of Cholesterol in Coronary Arteries
Towson : Research Site
A Pharmacodynamic Study With Ticagrelor in African American Patients
Towson : Research Site
A Pharmacodynamic Study With Ticagrelor in Hispanic Patients
Massachusetts
Haverhill : ActivMed Practices & Research, Inc.
Are Your Blood Sugar Numbers Out Of Control?
Haverhill : ActivMed Practices & Research, Inc.
Do you or a loved one have Type II Diabetes?
View More »
Ayer : Primary Care Cardiology Research
PRE-DETERMINE Cohort Study
Boston : Boston University Medical Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Boston : Mass General Hospital (MGH)
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Boston :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Boston : Beth Israel Deaconess Medical Center
An Observational Study of Cholesterol in Coronary Arteries
Boston : Massachusetts General Hospital
An Observational Study of Cholesterol in Coronary Arteries
Boston : Massachusetts General Hospital
Comparing Bivalirudin Versus Heparin/ GP IIB/IIA in Patients Undergoing PCI
Boston : Massachusetts General Hospital
Myocardial Stress Perfusion Imaging With Dual Source CT
Boston : Brigham and Women's Hospital
PRE-DETERMINE Cohort Study
Boston : Saint Elizabeth's Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Boston : Tufts Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Boston : Massachusetts General Hospital
Subclinical Atherosclerosis in HIV-infected Patients
Boston : Massachusetts General Hospital
The Massachusetts General Hospital Optical Coherence Tomography Registry
Boston : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Burlington : Lahey Clinic
An Observational Study of Cholesterol in Coronary Arteries
Fall River : NECCR Internal Medicine and Cardiology Associates, LLC
PRE-DETERMINE Cohort Study
Hyannis : Cape Cod Hospital Updated
PROMUS Element Plus US Post-Approval Study
Hyannis : Cape Cod Research Institute
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Natick : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
North Dartmouth : Hawthorn Medical Associates
PRE-DETERMINE Cohort Study
Springfield : Baystate Cardiology
PRE-DETERMINE Cohort Study
Worcester : University of Massachusettts Medical Center
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Michigan
Ann Arbor : University of Michigan Health System
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Ann Arbor :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Ann Arbor : University of Michigan Medical School
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Ann Arbor : University of Michigan Medical Center
PRE-DETERMINE Cohort Study
Cadillac : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
View More »
Dearborn : Oakwood Hospital & Medical Center
PRE-DETERMINE Cohort Study
Dearborn : Oakwood Hospital and Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Detroit : Wayne State University - Harper University Hospital
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Detroit : Henry Ford Hospital
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Detroit : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Grand Blanc : Genesys Regional Medical Center
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Grand Rapids : St. Mary's Healthcare (Trinity Health)
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Grand Rapids : Spectrum Health Hospitals
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Grandville :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Lansing : Thoracic & Cardiovascular Healthcare Foundation
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Lansing : Thoracic Cardiovascular Healthcare Foundation
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Mount Clemens : McLaren Macomb
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Mt. Clemens : McLaren Medical Center - Macomb
PRE-DETERMINE Cohort Study
Petoskey : Northern Michigan Hospital
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Petoskey : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Rochester Hills : Crittenton Shelton Heart Center:
An Observational Study of Cholesterol in Coronary Arteries
Royal Oak : William Beaumont Hospital
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Royal Oak : William Beaumont Hospital
An Observational Study of Cholesterol in Coronary Arteries
Royal Oak : William Beaumont Hospital
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
Royal Oak : William Beaumont Hospital
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Saginaw : Michigan Cardiovascular Institute
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
St. Joseph : Lakeland Hospitals at St. Joseph Updated
PROMUS Element Plus US Post-Approval Study
Ypsilanti : Michigan Heart
PRE-DETERMINE Cohort Study
Minnesota
Coon Rapids : Mercy Hospital Updated
PROMUS Element Plus US Post-Approval Study
Duluth : Essentia Health
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Duluth : St Mary's Duluth Clinic
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Minneapolis : Minneapolis Heart Institute at Abbott Northwestern Hospital
Alternative in Beta Blocker Intolerance: The ABBI Trial
Minneapolis : Minneapolis Heart Institute Foundation
Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry
View More »
Minneapolis : Minneapolis Heart Institute
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Minneapolis : Minneapolis VA Medical Center
PRE-DETERMINE Cohort Study
Minneapolis : North Memorial Medical Center Updated
PROMUS Element Plus US Post-Approval Study
Minneapolis : Minneapolis Heart Institute
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Minneapolis : Minneapolis Heart Institute Foundation
Safety and Feasibility Trial of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia
Rochester :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Rochester : Mayo Clinic
An Observational Study of Cholesterol in Coronary Arteries
Rochester : Mayo Clinic Updated
Assessment of Coronary Plaque Composition Using Optical Coherence Tomography
Rochester : Mayo Clinic
Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes
Rochester : Mayo Clinic
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Rochester : Mayo Clinic
Lp-PLA2, Progenitor Cells and Coronary Atherosclerosis in Humans AIM III
Rochester : Mayo Clinic
Non-Invasive EndoPAT Increases Diagnostic Yield of CAD by Coronary Angiography
Rochester : Mayo Clinic
Regadenoson Real Time Perfusion Imaging Trial-Optison
Saint Cloud : Saint Cloud Hospital
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
St. Cloud : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
St. Paul : United Hospital - St. Paul Heart Clinic Updated
PROMUS Element Plus US Post-Approval Study
Mississippi
Hattiesburg : Hattiesburg Clinic
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Hattiesburg : Forest County General Hospital Updated
PROMUS Element Plus US Post-Approval Study
Jackson : Jackson Heart Clinic
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Tupelo : Cardiology Associates of North Mississippi
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Missouri
Columbia : Missouri Cardiovascular Specialists, LLP
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Columbia : University of Missouri Health Care
PRE-DETERMINE Cohort Study
Kansas City : Cardiovascular Imaging Technologies (CVIT)
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Kansas City : Saint Luke's Mid America Heart and Vascular Institute
An Evaluation of Rigid Sternal Fixation in Supporting Bone Healing and Improving Postoperative Recovery
Kansas City : Saint Luke's Cardiovascular Consultants
Effectiveness Study of Single Photon Emission Computed Tomography (SPECT) Versus Positron Emission Tomography (PET) Myocardial Perfusion Imaging
View More »
Saint Louis : Saint Louis University School of Medicine
Feasibility and Diagnostic Accuracy of Myocardial Perfusion Imaging Using Early Imaging Protocol
Saint Louis : Gateway Cardiology, PC
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Springfield : Cox Medical Centers Updated
PROMUS Element Plus US Post-Approval Study
Springfield : St. John's Regional Health Center (Springfield) Updated
PROMUS Element Plus US Post-Approval Study
Springfield : Saint John's Regional Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Springfield : Cardiovascular Specialists of St. John's
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
St Louis : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
St. Louis : Saint Louis University School of Medicine
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
St. Louis : Washington University School of Medicine
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
St. Louis :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
St. Louis : Saint Louis University Hospital
An Observational Study of Cholesterol in Coronary Arteries
St. Louis : Center for Clinical Imaging Research (CCIR) at Washington University School of Medicine
Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson
St. Louis : Missouri Baptist Medical Center
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
St. Louis : St. Louis University
Regadenoson to Achieve Maximal Hyperemia for Fractional Flow Reserve in the Catheterization Lab
St. Louis : Mercy Hospital St. Louis
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Montana
Nebraska
Grand Island : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Omaha : The Cardiac Center of Creighton University
PRE-DETERMINE Cohort Study
Omaha : University of Nebraska Medical Center
Regadenoson Real Time Perfusion Imaging Trial-Optison
Nevada
Henderson : Cardiovascular Consultants of Nevada
Safety of Amiodarone and Ranolazine Together in Patients With Angina
Las Vegas : Las Vegas Radiology
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Las Vegas : Cardiovascular Consultants of Nevada
Safety of Amiodarone and Ranolazine Together in Patients With Angina
Las Vegas : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
New Hampshire
Lebanon : Dartmouth Hitchcock Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
New Jersey
Bridgewater : Advanced Heartcare, LLC
PRE-DETERMINE Cohort Study
Browns Mills : Deborah Heart and Lung Center
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Browns Mills : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Camden : Cooper University Hospital
Clinical Investigation for Safety and Efficacy Study of CELT ACD Arterial Closure Device
Cherry Hill : Associated Cardiovascular Consultants
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
View More »
Elizabeth : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Englewood : Englewood Hospital & Medical Center
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Hackensack : Hackensack University Medical Center Updated
PROMUS Element Plus US Post-Approval Study
Haddon Heights : Cardiovascular Associates of the Delaware Valley
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Haddon Heights : Our Lady of Lourdes Medical Center
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Linden : Research Site
A Pharmacodynamic Study With Ticagrelor in Hispanic Patients
Newark : Newark Beth Israel Medical Center
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Paterson : St. Joseph Regional Medical Center
PRE-DETERMINE Cohort Study
Summit :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Teaneck : Holy Name Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Wayne : Wayne Cardiology
PRE-DETERMINE Cohort Study
West Orange : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
New Mexico
Albuquerque : New Mexico VA Healthcare Systems
PRE-DETERMINE Cohort Study
Albuquerque : New Mexico Heart Institute
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Albuquerque : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
New York
Bronx : Biomedical Research Alliance of New York
Coronary Artery Disease - Adults
New York : Biomedical Research Alliance of New York
Coronary Artery Disease - Adults
New York : Biomedical Research Alliance of New York
Coronary Stent System
New York : The Rogosin Institute
This research study is being done to determine the safety and efficacy of an investigational drug over a 12-month period in subjects with High cholesterol levels and coronary heart disease who are already on lipid lowering therapy.
View More »
Albany : Albany Associates Cardiology
PRE-DETERMINE Cohort Study
Albany : Albany Associates in Cardiology
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Bronx : Montefiore Medical Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Brooklyn : East-West Research Inc.
PRE-DETERMINE Cohort Study
Brooklyn : New York Methodist Hospital
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Buffalo : Buffalo General Hospital/Kaleida Health
PRE-DETERMINE Cohort Study
Buffalo : Buffalo Heart Group
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Buffalo : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Jamaica : Jamaica Hospital Medical Center
PRE-DETERMINE Cohort Study
Kingston : Mid-Valley Cardiology
PRE-DETERMINE Cohort Study
Liverpool : SJH Cardiology Associates
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Manhasset : North Shore University Hospital, NY
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Mineola : Winthrop-University Hospital
PRE-DETERMINE Cohort Study
N. Massapequa :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
New Hyde Park : Long Island Jewish Medical Center
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
New York : Columbia University Medical Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
New York : Mount Sinai Medical Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
New York : Columbia Universtiy Medical Center
An Observational Study of Cholesterol in Coronary Arteries
New York : Mount Sinai School of Medicine
An Observational Study of Cholesterol in Coronary Arteries
New York : Mount Sinai School of Medicine Hospital
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
New York : New York Presbyterian Hospital
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
New York : Novartis Investigative Site
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
New York : Columbia University Health Center
PRE-DETERMINE Cohort Study
New York : Gotham Cardiovascular
PRE-DETERMINE Cohort Study
New York : Columbia University Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
New York : NYU College of Medicine
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
New York : Mount Sinai School of Medicine
The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Levels With Coronary Artery Disease After Successful Intervention of the Blockage or Narrowed Heart Artery
New York : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
New York, : New York Presbyterian Hospital
Clinical Investigation for Safety and Efficacy Study of CELT ACD Arterial Closure Device
Poughkeepsie : Hudson Valley Heart Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Roslyn : St. Francis Hospital
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Roslyn : St. Francis Hospital
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Stony Brook : Stony Brook University Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Stony Brook : Stony Brook University Medical Center
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Stony Brook : Stony Brook Medical Center
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Syracuse : St. Joseph's Hospital Health Center
Resolute Integrity US
Utica : St. Elizabeth Medical Center - Hotvedt
PRE-DETERMINE Cohort Study
Utica : St. Elizabeth Medical Center Updated
PROMUS Element Plus US Post-Approval Study
Utica : Central New York Cardiology
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Valhalla : Westchester Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Westfield : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Williamsville : Buffalo Cardiology and Pulmonary Associates, PC
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Williamsville : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
North Carolina
Raleigh : Rex Healthcare
ALERTS (AngeLmed for Early Recognition and Treatment of STEMI) Study
Raleigh : Rex Healthcare
TRANSLATE- Treatment with ADP receptor inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome Registry
View More »
Asheville : Asheville Cardiology Associates
PRE-DETERMINE Cohort Study
Asheville : Asheville Cardiology Associates
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Charlotte : UNC School of Medicine
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Charlotte : Mid-Carolina Cardiology Presbyterian Hospital Updated
PROMUS Element Plus US Post-Approval Study
Charlotte : Mid Carolina Cardiology
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Charlotte : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Durham : Duke University Medical Center
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Durham : Veterans Affairs Medical Center, Duke University Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Durham : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Elizabeth City : Eastern Carolina Cardiovascular
PRE-DETERMINE Cohort Study
Gastonia : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Greensboro : LeBauer Cardiovascular Research Foundation
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Greensboro : Moses H. Cone Memorial Hospital-LeBauer Cardiovascular Research Foundation
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
High Point : Carolina Cardiology Associates
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Lenoir : Northstate Clinical Research
PRE-DETERMINE Cohort Study
Matthews : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Pinehurst : Pinehurst Medical Clinic, Inc.
PRE-DETERMINE Cohort Study
Raleigh : Wake Heart Research
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Raleigh : Rex Hospital
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Raleigh : Wake Heart Research, LLC
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Salisbury : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Sanford : Sanford Cardiology
PRE-DETERMINE Cohort Study
Statesville : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Wake Forest : Triangle Primary Care
Investigation of a Novel Gene Expression Test for the Diagnosis of Obstructive Coronary Artery Disease on Physician's Practice Pattern
Wilmington : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Winston-Salem : Wake Forest
PRE-DETERMINE Cohort Study
Winston-Salem : Forsyth Medical Center
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
North Dakota
Bismarck : St. Alexius Medical Center
A study to determine whether the investigational drug being studied might prevent future cardiovascular events (such as, heart attacks or strokes) in patients.
View More »
Grand Forks : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Ohio
Akron : Northeast Ohio Cardiovascular Specialists
PRE-DETERMINE Cohort Study
Cincinnati : The Christ Hospital
A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System
Cincinnati : University of Cincinnati
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Cincinnati : The Lindner Clinical Trial Center
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Cincinnati : University of Cincinnati Medical Center
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
View More »
Cincinnati : University of Cincinnati
PRE-DETERMINE Cohort Study
Cincinnati : Lindner Center for Research and Education at Christ Hosp
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Cincinnati : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Cleveland : Cleveland Clinic Foundation
Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique
Cleveland : Cleveland Clinic Foundation
Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry
Cleveland : University Hospital of Cleveland, Harrington-McLaughlin Heart and Vascular Institute
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Cleveland : The MetroHealth System
PRE-DETERMINE Cohort Study
Cleveland : The Cleveland Clinic Foundation
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Cleveland : The Cleveland Clinic Foundation
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Cleveland : University Hospitals of Cleveland
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Cleveland : University Hospitals of Cleveland
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Columbus : OhioHealth Research Institute
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Columbus : The Ohio State University
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Columbus : Ohio Health Research Institute
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Columbus : Ohio State Univeristy
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Elyria : North Ohio Research, Ltd.
PRE-DETERMINE Cohort Study
Elyria : EMH Regional Medical Center
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Elyria : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Fairfield : Mercy Medical Associates
PRE-DETERMINE Cohort Study
Garfield Heights : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Kettering : Kettering Medical Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Middleburg Heights : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Sandusky : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Toledo : Northwest Ohio Cardiology Consultants/The Toledo Hospital
PRE-DETERMINE Cohort Study
Toledo : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Westlake : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Youngstown : Comprehensive Physicians Associates
Investigation of a Novel Gene Expression Test for the Diagnosis of Obstructive Coronary Artery Disease on Physician's Practice Pattern
Zanesville : Cardiology Associates of Southeast Ohio, Inc.
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Oklahoma
Oklahoma City : Oklahoma Foundation for Cardiovascular Research
Seeking Oklahomans with Diabetes who also have Coronary Artery Disease.
View More »
Oklahoma City : Oklahoma City VA Medical Center Veterans Research and Education Foundation
PRE-DETERMINE Cohort Study
Oklahoma City : Oklahoma Foundation for Cardiovascular Research
PRE-DETERMINE Cohort Study
Oklahoma City : Oklahoma City Veterans' Affairs Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Oklahoma City : South Oklahoma Heart Research
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Oklahoma City : Oklahoma Heart Hospital
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Oklahoma City : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Tulsa : St. Francis Hospital Updated
PROMUS Element Plus US Post-Approval Study
Tulsa : Oklahoma Heart Institute at Utica
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Oregon
Portland :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Portland : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Springfield : Oregon Heart and Vascular Institute
Low Dose One-Day Tc99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera For Detection of Coronary Disease
Pennsylvania
Altoona : Blair Medical Associates, Inc. Clinical Trials Dept.
A Phase 3b, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Study to Evaluate the Effect of Dalcetrapib 600 mg on Cardiovascular (CV) Events in Adult Patients With Stable Coronary Heart Disease (CHD), CHD Risk Equivalents or at Elevated Risk for Cardiovascular Disease (CVD).
View More »
Abington : Abington Memorial Hospital
PRE-DETERMINE Cohort Study
Beaver : The Heart and Vascular Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Beaver : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Bethlehem : St. Luke's Bethlehem
PRE-DETERMINE Cohort Study
Danville : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Doylestown : Doylestown Cardiology Associates
PRE-DETERMINE Cohort Study
Doylestown : Doylestown Hospital Updated
PROMUS Element Plus US Post-Approval Study
Doylestown : Central Bucks Cardiology
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Doylestown : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Erie : Saint Vincent Health Care Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Erie : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Harrisburg : Pinnacle Health Cardiovascular Institute/ Associated Cardiologists
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Harrisburg : Pinnacle Heart & Vascular Institute
An Observational Study of Cholesterol in Coronary Arteries
Harrisburg : Pinnacle Health Cardiovascular Insititute
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
Jersey Shore : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Lancaster :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Lancaster : Lancaster Heart & Stroke Foundation
PRE-DETERMINE Cohort Study
Lewistown : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Philadelphia : Temple University Hospital
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Philadelphia : Drexel University College of Medicine
PRE-DETERMINE Cohort Study
Philadelphia : Presbyterian University of Pennsylvania Medical Center Updated
PROMUS Element Plus US Post-Approval Study
Philadelphia : University of Pennsylvania
Stem Cell Implantation in Patients Undergoing CABG
Philadelphia : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Pittsburgh : Allegheny General Hospital
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Pittsburgh : Presbyterian University Hospital
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Pittsburgh : UPMC Presbyterian Hospital
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Pittsburgh : University of Pittsburgh Medical Center
Identification of Carotid Vasa Vasorum and Correlation With Acute Coronary Events
Pittsburgh : University of Pittsburgh Medical Center
PITT PCI Xience Registry
Pittsburgh : Allegheny-Singer Research Institute (Allegheny General Hospital)
PRE-DETERMINE Cohort Study
Pittsburgh : University of Pittsburgh Medical Center
PRE-DETERMINE Cohort Study
Pittsburgh : Veterans Administration Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Pittsburgh : Allegheny-Singer Research Institute
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Pittsburgh : University of Pittsburgh Medical Center
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Pittsburgh : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Port Matilda : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Sayre : Donald Guthrie Foundation for Education and Research
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Scranton : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Sellersville : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Wilkes-Barre : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Wormleysburg : Pinnacle Health System
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Wyomissing : Berks Cardiologists, Ltd.
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
York : York Hospital /Wellspan Health
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
York : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Rhode Island
Providence : Rhode Island Hospital
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Providence : Rhode Island Hospital
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Providence : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
South Carolina
Anderson : AnMed Health
PRE-DETERMINE Cohort Study
Charleston : Medical University of South Carolina
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Charleston : Medical University of South Carolina Hospital
An Observational Study of Cholesterol in Coronary Arteries
Charleston : Medical University of South Carolina Hospital
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
Charleston : VA Medical Center - Charleston
PRE-DETERMINE Cohort Study
View More »
Charleston : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Charlston :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Columbia : Columbia Cardiology Consultants
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Columbia : Sisters of Charity Providence Hospitals
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Greenville : St. Francis Health System - St. Francis Hospital Updated
PROMUS Element Plus US Post-Approval Study
Greenville : University Medical Center-Greenville Memorial Hospital Updated
PROMUS Element Plus US Post-Approval Study
Greenville : Upstate Cardiology
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Myrtle Beach : Grand Strand Regional Medical Center Updated
PROMUS Element Plus US Post-Approval Study
Rock Hill : Carolina Cardiology Associates
PRE-DETERMINE Cohort Study
Spartanburg : Spartanburg Regional Medical Center
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Spartanburg : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
South Dakota
Rapid City : Black Hills Cardiovascular Research
PRE-DETERMINE Cohort Study
Rapid City : Rapid City Regional Hospital Updated
PROMUS Element Plus US Post-Approval Study
Rapid City : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Sioux Falls : Avera Heart Hospital of South Dakota Updated
PROMUS Element Plus US Post-Approval Study
Sioux Falls : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Tennessee
Bristol : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Jackson : Research Associates of Jackson
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Johnson City : Cardiology Consultants
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Johnson City : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Kingsport : Wellmont CVA Heart Institute
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
View More »
Knoxville : Cardiovascular Research of Knoxville - St. Mary's Health Care System, Inc.
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Knoxville : Center for Biomedical Research
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Knoxville : Cardiovascular Research of Knoxville
PRE-DETERMINE Cohort Study
Knoxville : Cardiovasular Research of Knoxville
PRE-DETERMINE Cohort Study
Knoxville : University of Tennessee
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Memphis : Memphis VA Medical Center
PRE-DETERMINE Cohort Study
Memphis : Stern Cardiovascular Foundation
PRE-DETERMINE Cohort Study
Memphis : Methodist University Hospital
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Nashville : Vanderbilt Heart and Vascular Institute
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Nashville :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Nashville : Centennial Heart Cardiovascular Consultants, LLC
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Nashville : St. Thomas Hospital Heart
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Nashville : Vanderbilt Medical Center
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Texas
Amarillo : Cardiology Center of Amarillo, LLP
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Austin : South Austin Hospital Updated
PROMUS Element Plus US Post-Approval Study
Austin : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Beaumont : Research Site
A Pharmacodynamic Study With Ticagrelor in African American Patients
Corpus Christi/Texas : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
View More »
Dallas : Dallas VA Medical Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Dallas :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Dallas : Veterans Affairs, North Texas Health Care Systems
An Observational Study of Cholesterol in Coronary Arteries
Dallas : Veterans Affairs North Texas Health Care Systems
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
Dallas : CRSTI/Medical City Dallas
Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques
Dallas : Presbyterian Hospital of Dallas Updated
PROMUS Element Plus US Post-Approval Study
Dallas : VA North Texas Medical Center Updated
PROMUS Element Plus US Post-Approval Study
Dallas : North Texas Healthcare System, Dept. of Veteran's Affairs
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Dallas : Medical City Hospital
Study to Improve Long Term Vein Graft Patency After Coronary Bypass Surgery by Using a Novel Endoscopic Harvesting Technique
Dallas : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Galveston : University of Texas Medical Branch
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Georgetown : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Harker Heights : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Houston : Excel Diagnostics and Nuclear Oncology Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Houston : The Methodist Hospital
Diagnostic Study of Rapid Regadenoson Stress Cardiovascular Magnetic Resonance (CMR) to Detect Coronary Artery Disease
Houston : Texas Heart Institute
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Houston : Texas Heart Institute, St. Luke's Episcopal Hospital
LifeVest Post-CABG Registry
Houston : Non-Invasive Cardiovascular PA
PRE-DETERMINE Cohort Study
Houston : St. Luke's Episcopal Hospital
PRE-DETERMINE Cohort Study
Houston : Baylor College of Medicine
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Houston : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Humble : Humble Cardiology Associates
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Katy : Katy Cardiology
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Mission : Gamma Medical Research Inc.
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Plano : The Heart Hospital Baylor Plano
Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques
Plano : The Heart Hospital Baylor Plano
Study to Improve Long Term Vein Graft Patency After Coronary Bypass Surgery by Using a Novel Endoscopic Harvesting Technique
Plano : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
San Antonio : Novartis Investigative Site
Efficacy of LCQ908 on Cardiovascular Risk
San Antonio : San Antonio Endovascular and Heart Institute
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
San Antonio : South Texas Cardiovascular Consultants
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
San Antonio : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Temple : Scott & White Memorial Hospital
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Temple : Scott & White Memorial Hospital
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Tomball : West Houston Area Clinical Trial Consultants, LLC
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Tyler : Cardiovascular Associates of East Texas
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Victoria : Victoria Heart and Vascular Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Victoria : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Waco : Providence Health Center
PRE-DETERMINE Cohort Study
Utah
Salt Lake City : Optimum Clinical Research, Inc.
Are you currently taking medication for your cholesterol, but your LDL (bad cholesterol) is still too high? If so, you may be able to participate in this cutting edge study.
Salt Lake City : Optimum Clinical Research, Inc.
Those with diabetes know they are at a higher risk of having heart attacks , strokes, and other cardiovascular complications. This study is looking at the effects of a new diabetes medication on cardiovascular risks in patient at high risk of having another stroke or heart attack.
View More »
Draper : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Layton : Utah Cardiology, PC
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Murray : Intermountain Medical Center
PRE-DETERMINE Cohort Study
Ogden : McKay-Dee Heart Services
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Salt Lake City : University of Utah
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Salt Lake City : Intermountain Healthcare
Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using CT Angiography, Following Core 64
Vermont
Burlington : Fletcher Allen Health Care
Cangrelor Ticagrelor Transition Study
Burlington : University of Vermont Medical Center, Fletcher Allen Health Care
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Virginia
Burke : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Charlottesville : University of Virginia Health System
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Charlottesville : University of Virginia
Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry
Charlottesville : University of Virginia
Less Invasive Detection and Treatment of Very Early Coronary Artery Disease in Patients With Diabetes Mellitus
Falls Church : Inova Heart and Vascular Institute
CorMatrix ECM Study: To Identify Inflammatory Markers Following CABG With/Without ECM
View More »
Norfolk : Sentara Cardiovascular Research Institute
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Norfolk : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Richmond : McGuire Veteran Affairs Medical Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Richmond : Chippenham Medical Center Updated
PROMUS Element Plus US Post-Approval Study
Richmond : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Roanoke : Roanoke Heart Institute
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Roanoke : Carilion Cardiology Clinic
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Roanoke : Carilion Roanoke Memorial Hospital Updated
PROMUS Element Plus US Post-Approval Study
Virginia Beach : Cardiovascular Associates Virginia Beach
PRE-DETERMINE Cohort Study
Virginia Beach : Cardiovascular Associates, Ltd.
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Winchester : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Washington
Kirkland : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Olympia : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Renton : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Seattle : Swedish Medical Center
An Observational Study of Cholesterol in Coronary Arteries
Seattle : University of Washington
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
View More »
Seattle : Swedish Medical Center
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Seattle : Swedish Medical Center
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Seattle : The Heart Institute at Virginia Mason
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Seattle : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Seattle : University of Washington Coronary Atherosclerosis Research Lab
Using Magnetic Resonance Imaging to Evaluate Carotid Artery Plaque Composition in People Receiving Cholesterol-Lowering Medications (The CPC Study)
Spokane : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Tacoma : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Walla Walla : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Wenatchee : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Yakima : Yakima Heart Center
Using Magnetic Resonance Imaging to Evaluate Carotid Artery Plaque Composition in People Receiving Cholesterol-Lowering Medications (The CPC Study)
Wisconsin
Madison : University of Wisconsin Hospitals
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Madison : Meriter Hospital Updated
PROMUS Element Plus US Post-Approval Study
Milwaukee : Aurora Health Care
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Wausau : Aspirus Heart & Vascular Institute
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Wausau : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Argentina
Adrogue : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Bahia Blanca : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Buenos Aires : Instituto Cardiovascular de Buenos Aires-ICBA
ABSORB EXTEND Clinical Investigation
Buenos Aires : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Buenos Aries : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
View More »
Caba : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Ciudad Autonoma de Buenos Aires :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Ciudad Autonoma de Buenos Aires : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Ciudad Autónoma de Buenos Aires : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Cordoba : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Córdoba :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Corrientes : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Junin : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
La Plata : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Mar del Plata : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Mendoza : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Ramos Mejia : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Rosario : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Santa Fe : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Tucuman : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Australia
Adelaide : Royal Adelaide Hospital
ABSORB PHYSIOLOGY Clinical Investigation
Auchenflower : Wesley Hospital
ABSORB EXTEND Clinical Investigation
Auchenflower : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Ballarat : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Bedford Park : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
View More »
Camperdown, NSW :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Caulfield South : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Coffs Harbour : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Concord : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Epping : Northern Hospital
Apposition Assessed Using Optical Coherence Tomography of Chromium Stents Eluting Everolimus From Cobalt Versus Platinum Alloy Platforms
Frankston : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Fremantle : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Garran, ACT : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Gosford : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Heidelberg : Austin Health
ABSORB PHYSIOLOGY Clinical Investigation
Joondalup : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Kippa Ring : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Liverpool : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Malvern : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Melbourne : St. Vincent's Hospital
ABSORB EXTEND Clinical Investigation
Melbourne : Monash Medical Centre
ABSORB PHYSIOLOGY Clinical Investigation
Nedlands : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Perth :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Randwick : Eastern Heart Clinic, The Prince of Wales Hospital
ABSORB EXTEND Clinical Investigation
Sherwood : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
South Brisbane :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Southport QLD :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Victoria : Monash Medical Center
ABSORB EXTEND Clinical Investigation
Austria
Graz : Landeskrankenhaus Graz West
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Innsbruck : Innsbruck Universitaetsklinik
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Linz : Allgemeines Krankenhaus Linz
ABSORB EXTEND Clinical Investigation
Linz : Allgemeines Krankenhaus der Stadt Linz
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Saint Pölten : Landesklinikum Sankt Pölten
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
View More »
Salzburg : St. Johanns Spital
Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis
Vienna : AKH Wien
BIOFLOW-III Austria Satellite Registry
Vienna : Krankenhaus Hietzing
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Vienna : Wilhelminenspital der Stadt Wien
Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis
Vienna : Allgemeines Krankenhaus Wien
Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis
Vienna : Donauspital der Stadt Wien
Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis
Wien : Medizinische Universität Wien
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Wien : Wilhelminenspital der Stadt Wien
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Belgium
Aalst : Onze-Lieve VrouweZiekenhuis
ABSORB EXTEND Clinical Investigation
Aalst : OLV Ziekenhuis Aalst
Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System
Aalst : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Antwerp : Ziekenhuis Netwerk Antwerpen Middelheim
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Antwerpen : ZNA Middelheim
Safety and Effectiveness of the Coronary Momo Stent
View More »
Antwerpen : Middelheim Ziekenhuis
Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System
Antwerpen : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Antwerpen, Linderreef 1 : Academic Hospital Middelheim
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Bonheiden : Imelda Ziekenhuis
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Bonheiden : Imelda vzw
Safety and Effectiveness of the Coronary Momo Stent
Bonheiden : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Brugge : Algemeen Ziekenhuis Sint-Jan
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Brugge : AZ Sint Jan
Safety and Effectiveness of the Coronary Momo Stent
Brussel : UZ Brussel
Safety and Effectiveness of the Coronary Momo Stent
Brussels : Abbott Vascular International BVBA
ABSORB FIRST Registry
Brussels : Abbott Vascular International BVBA
ABSORB II Randomized Controlled Trial
Bruxelles : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Edegem :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Genk : ZOL Genk, Campus Saint Jan
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Genk : Ziekenhuis Oost-Limburg
Safety and Effectiveness of the Coronary Momo Stent
Genk : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Gent : AZ Maria Middelares
Safety and Effectiveness of the Coronary Momo Stent
Haine St. Paul :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Hasselt : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
La Louvière : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Leuven :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Leuven : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Liege : Centre Hospitalier Universitaire Sart Tilman Liège
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Liège : CHU Liège - Sart Tilman
Acrobat Coronary Stent System Effectiveness European Study
Liège : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Roeselaere : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Yvoir : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Brazil
Belo Horizonte : Irmandade Santa Casa de Misericórdia de Belo Horizonte
Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent
Belo Horizonte : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Blumenau : Hospital Santa Isabel
Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent
Campinas : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Colatina - ES : São Bernardo Apart Hospital
Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent
View More »
Curitiba : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Franca - SP : Santa Casa de Franca
Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent
Goiânia : Hospital São Salvador Goiânia
Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent
Goiânia : Hospital Santa Genoveva
Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent
Goiânia : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Natal : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Patos de Minas - MG : Hospital Vera Cruz
Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent
Pelotas : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Porto Alegre : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Recife - PE : Instituto de Medicina Integral Professor Fernando Figueira - IMIP
Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent
Rio de Janeiro :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Rio de Janeiro : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Salvador : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
São José do Rio Preto : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
São José do Rio Preto - SP : Santa Casa de Misericórdia de São José do Rio Preto
Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent
Sao Paulo :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Sao Paulo : Sociedade Beneficente Isreaelita Brasileira Hospital Albert Einstein
ABSORB EXTEND Clinical Investigation
Sao Paulo : Instituto de Cardiologia Dante Pazzanese Unidadae II Recepcao de Angioplastia
ABSORB EXTEND Clinical Investigation
Sao Paulo : Instituto Dante Pazzanese de Cardiologia
Safety Study of a Bioresorbable Coronary Stent
São Paulo : Hospital São Paulo - UNIFESP
Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent
São Paulo : Instituto de Assistência Médica ao Servidor Público Estadual - Iamspe
Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent
São Paulo : Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da USP
Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent
São Paulo : Instituto Dante Pazzanese de Cardiologia
Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent
São Paulo : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Uberlandia : Instituto Coração Triângulo Mineiro
ABSORB EXTEND Clinical Investigation
Bulgaria
Dimitrovgrad : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Pleven : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Plovdiv : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Ruse : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Sofia : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
View More »
Veliko Tarnovo : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Canada
Ajax : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Bay Roberts : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Brampton : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Chicoutimi :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Edmonton : University of Alberta and Mazankowski Alberta Heart Institute
Autologous Cell Therapy for Ischemic Heart Failure
View More »
Edmonton : Royal Alexandra Hospital
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Edmonton : University of Alberta Hospital
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Edmonton : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Gatineau : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Greenfield Park : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Halifax : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Hamilton : Hamilton General Hospital
Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting: The PAPA CABG Study
Hamilton : Hamilton Health Sciences, General Site
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Hamilton : Hamilton Health Sciences
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Hamilton : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Kelowna : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Kitchener : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Levis : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
London : University of Western Ontario
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
London : Robarts Research Institute
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Mississauga : KMH Cardiology and Diagnostic and MRI Centres
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Mississauga : Trillium Health Centre
Graft Patency in Beating Heart Vs. Conventional CABG Using Cardiac CT
Mississauga : Entralogix Clinical Research, Inc.
PRE-DETERMINE Cohort Study
Mississauga : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Montreal :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Montreal : Montreal Heart Institute
ABSORB EXTEND Clinical Investigation
Montreal : Montreal Heart Institute
Autologous Cell Therapy for Ischemic Heart Failure
Montreal : Centre Hospitalier de l'Universite de Montreal (CHUM)
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Montreal : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Montreal : Innovaderm Research Inc
Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis
Montréal : Hôpital du Sacré-Coeur de Montréal
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Montréal : Montreal Heart Institute
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
New Westminister : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
New Westminster : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Oshawa : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Ottawa : University of Ottawa Heart Institute
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Ottawa : University of Ottawa Heart Institute
ABSORB EXTEND Clinical Investigation
Ottawa : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Quebec : Institut Universitaire de Cardiologie et de Pneumologie de Québec
ABSORB EXTEND Clinical Investigation
Quebec City : Institut Universitaire de Cardiologie et de Pneumologie de Québec
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Quebec City : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Saint Charles-Borromee : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Saint John : New Brunswick Heart Centre
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Sainte-Foy :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Scarborough : Scarborough Cardiology Research Associates
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Sherbrooke : Centre Hospitalier Universitaire de Sherbrooke (CHUS)
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Sherbrooke : Centre Hospitalier Universitaire de Sherbrooke
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Sherbrooke : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
St. John's : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
St-Hyacinthe : Clinique Médicale Dr Isabelle Delorme
Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis
Surrey : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Thornhill : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Toronto : St. Michael's Hospital
ABSORB EXTEND Clinical Investigation
Toronto : Saint Michael's Hospital
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Toronto : University Health Network
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Toronto : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Trois Rivières : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Truro : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Vancouver :
A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome
Vancouver : Vancouver General Hospital
PRE-DETERMINE Cohort Study
Vancouver : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Victoria : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Winnipeg : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Chile
Santiago : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Talcahuano : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Viña del Mar : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
China
Colombia
Bogota : Country Club de Bogota
Real-life Experience of the Use of Isomers as METPURE XL (S (-) Metoprolol Succinate) for Evaluation of Efficacy, Safety and Tolerability in the Management of Cardiovascular Disease in Colombian Patients
Croatia
Osijek :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Zagreb :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Czech Republic
Brno : Fakultní nemocnice Brno
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Caslav : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Chomutov : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Chrudim : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Hradec Kralove :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
View More »
Jihlava : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Karlovy Vary : Karlovarská krajská nemocnice a.s.
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Kladno : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Kolin : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Kromeriz : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Liberec : Krajská nemocnice Liberec a.s.
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Milevsko : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Pisek : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Prague : General University Hospital
GLP-1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Diabetic Patients With Aortocoronary Bypass
Praha 1 :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Praha 2 : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Slany : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Svitavy : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Tabor : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Usti nad Orlici : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Denmark
Aarhus : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Århus N : Århus University Hospital
ABSORB EXTEND Clinical Investigation
Esbjerg : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Koebenhavn OE : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Silkeborg : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
View More »
Skejby : Aarhus University Hospital
The Nordic-Baltic Bifurcation Study IV
Vejle : Vejle Medical Center
Dual Source CT Angiography for Detection of Coronary Artery Stenoses
Estonia
Tallinn : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Tartu : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Finland
Helsinki : Helsinki University Hospital
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Turku : Turku PET Centre
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
France
Aix en Provence cedex 1 : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Annecy : Centre Hospitalier de la Région Annecienne
Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment
Arras : Centre Hospitalier d'Arras
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Avignon : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Besançon Cedex : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
View More »
Bron : Hôpital Cardiovasculaire et Pneumologique Louis Pradel
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
Bron Cedex : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Clermont-Ferrand : CHU Clermont-Ferrand
Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in Side Branches of de Novo Bifurcation Lesions (DEBSIDE)
Colmar : Hôpital Albert Schweitzer
Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment
Corbeil Essonnes : Centre Hospitalier Sud Francilien
Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment
Créteil : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Dijon : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Evecquemont : Centre Cardiologique d'Evecquemont
Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in Side Branches of de Novo Bifurcation Lesions (DEBSIDE)
Haguenau : Centre Hospitalier d'Haguenau
Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment
Lille Cedex : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Lyon : Centre Hospitalier Saint Joseph et Saint Luc
Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment
Marseille cedex 5 : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Massy : Hôpital Privé Jacques Cartier
Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment
Massy : Institut hospitalier Jacques Cartier
Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in Side Branches of de Novo Bifurcation Lesions (DEBSIDE)
Metz Cedex 03 : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Montpellier : Hôpital Arnaud de Villeneuve
Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment
Nantes : CHU Nantes
Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in Side Branches of de Novo Bifurcation Lesions (DEBSIDE)
Nantes Cedex 1 : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Narbonne Cedex : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Nimes : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Nîmes : Centre Hospitalier Universitaire Caremeau
Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment
Ollioules : Polyclinique les Fleurs
ARTDIVA Study : First in Man Safety Evaluation of the ART18Z Bioresorbable Stent
Paris : Hôpital Européen Georges Pompidou
ARTDIVA Study : First in Man Safety Evaluation of the ART18Z Bioresorbable Stent
Paris : Groupe Hospitalier Pitié Salpêtrière
Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment
Paris : Hôpital Bichat-Claude Bernard
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Paris : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Paris : Centre Hospitalo-Universitaire Pitié-Salpetrière
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
Paris Cedex 13 : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Paris Cedex 18 : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Pessac : Hôpital Haut Leveque
ARTDIVA Study : First in Man Safety Evaluation of the ART18Z Bioresorbable Stent
Pessac : Hôpital du Haut-Lévêque
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
Pessac cedex : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Pontoise : Centre Hospitalier Rene Dubos
Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment
Pringy : Centre Hospitalier d'Annecy
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Rennes : Hôpital Pontchaillou
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
Roubaix : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Rouen : Clinique Saint-Hilaire
Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in Side Branches of de Novo Bifurcation Lesions (DEBSIDE)
Strasbourg : Hôpitaux Universitaires de Strasbourg - Nouvel Hôpital Civil
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
Strasbourg cedex : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Toulouse : Hôpital Rangueil
ARTDIVA Study : First in Man Safety Evaluation of the ART18Z Bioresorbable Stent
Toulouse : Clinique Pasteur
ARTDIVA Study : First in Man Safety Evaluation of the ART18Z Bioresorbable Stent
Toulouse : Clinique Pasteur
Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in Side Branches of de Novo Bifurcation Lesions (DEBSIDE)
Toulouse : Centre Hospitalier de Rangueil
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
Toulouse Cedex 09 : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Toulouse Cedex 9 : Hôpital Rangueil
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Tourcoing : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Villeneuve Saint Georges : CHI de Villeneuve
Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment
Germany
Aachen :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Aachen : Universtiy Hospital of Aachen, Department of Cardiology
Heart Cycle GEx (Guided- Exercise- Main Trial)
Aachen : University Hospital Aachen
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
Aschaffenburg : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Bad Nauheim : Kerckhoff-Klinik SGmbh
A Multinational Trial to Evaluate the Longterm Safety of the Parachute Implant System
View More »
Bad Nauheim : Kerckhoff-Klinik GmbH
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Bad Oeynhausen : Herz- und Diabeteszentrum Nordrhein Westfalen
Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery
Bad Oeynhausen : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Bad Segeberg : Herzzentrum Bad Segeberger Klinik
Comparison Between FFR Guided Revascularization Versus Conventional Strategy in Acute STEMI Patients With MVD.
Berlin :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Berlin : Charité - Universitätsmedizin Berlin, Charité Centrum 11 für Herz-, Kreislauf- und Gefäßmedizin
Clinical Performance of the Pantera Lux DCB Versus the Orsiro DES in Patients With "-Limus" DES-ISR.
Berlin : Innere Medizin Kardiologie - Charité Centrum 11, Campus Benjamin Franklin
Clinical Performance of the Pantera Lux DCB Versus the Orsiro DES in Patients With "-Limus" DES-ISR.
Berlin : Deutsches Herzzentrum Berlin
Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery
Berlin : Vivantes Klinikum im Friedrichshain
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Berlin : German Heart Institute Berlin
Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation
Berlin : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Bernau : Herzzentrum Brandenburg in Bernau
ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease
Bernau : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Bielefeld : Städtische Kliniken Bielefeld gGmbH
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Bochum : University Hospital of Bochum, Department of Dermatology
Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up
Bonn : Arzt St. Marien-Hospital Abt. Innere Medizin
A Multinational Trial to Evaluate the Longterm Safety of the Parachute Implant System
Braunschweig : Klinikum Braunschweig, Department of Cardiothoracic Surgery
Incidence of Acute Cerebrovascular Events Using Either Minimized or Standard Cardiopulmonary Bypass Circuit
Bremen : Klinikum Links der Weser - Senator-Wessling-Str. 1
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
Coburg : Klinikum Coburg GmbH
ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease
Coburg : Kardiologie - Angiologie - Pneumologie, Klinikum Coburg
Clinical Performance of the Pantera Lux DCB Versus the Orsiro DES in Patients With "-Limus" DES-ISR.
Deggingen : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Delitzsch : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Dorsten : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Dortmund : HIV Outpatient Department
Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up
Dortmund : Sankt Johannes Hospital
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Dresden : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Duisburg : Health Center
Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up
Erlangen : University of Erlangen
Dual Source CT Angiography for Detection of Coronary Artery Stenoses
Eschweiler : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Essen : Elisabeth-Krankenhaus Essen GmbH
ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease
Essen : University Hospital, West German Heart Center Essen
Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up
Essen : University Hospital, Department of Dermatology and Venerology
Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up
Essen : Contilia Heart- and Vascular Center, Elisabeth Krankenhaus
Clinical Performance of the Pantera Lux DCB Versus the Orsiro DES in Patients With "-Limus" DES-ISR.
Essen : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Frankfurt/M. : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Freiburg :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Freiburg Im Breisgau : Department of Internal Medicine III (Cardiology), University of Freiburg im Breisgau
European Multicenter, Randomized, Comparative Efficacy/Safety Study of the Mar-Tyn TiN-Coated Stent
Goch : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Greifswald : Ernst-Moritz-Arndt-Universität
Immunoadsorption and Immunoglobulin Substitution for Heart Failure After Myocardial Infarction
Gueglingen : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Haag : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Hamburg :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Hamburg : Medical Care Center Prof. Mathey, Prof. Schofer GmbH
ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease
Hamburg : Roentgenpraxis Hamburg
Dual Source CT Angiography for Detection of Coronary Artery Stenoses
Hamburg : Universitäres Herzzentrum Hamburg
Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery
Hamburg : University Clinica Eppendorf
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Hamburg : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Hannover : Hannover Medical School, Clinic for Cardiac, Thoracic, Transplantation and Vascular Surgery
Incidence of Acute Cerebrovascular Events Using Either Minimized or Standard Cardiopulmonary Bypass Circuit
Hannover : Medical School Hannover
Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery
Hannover : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Heidelberg :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Heidelberg : Uni.Klinikum Heidelberg
ABSORB EXTEND Clinical Investigation
Heidelberg : Abt. Herzchirugie, Universitätsklinikum Heidelberg
Phase III Study Comparing Two Methods of Cardioplegia in Coronary Artery Bypass Surgery
Heidelberg : Universitätsklinikum Heidelberg
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Heidelberg : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Herford : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Jena : Klinikum der Friedrich Schiller University
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Kelkheim : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Kiel : Universitätsklinikum Schleswig-Holstein
ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease
Kiel : Universitätsklinikum Schleswig-Holstein
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
Koeln :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Kuenzing : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Langen : Asklepios-Kliniken Langen
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Leipzg : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Leipzig : Herzzentrum Universität Leipzig
Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery
Leipzig : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Lengerich : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Lubeck : UniversitatsKlinikum Schleswig-Holstein
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
Magdeburg :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Magdeburg : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Mainz : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Minden : Kardiologie /Intern. Intensivmedizin, Johannes Wesling Klinikum Minden
Clinical Performance of the Pantera Lux DCB Versus the Orsiro DES in Patients With "-Limus" DES-ISR.
Mönchengladbach : Kliniken Maria Hilf GmbH
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Muehldorf : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Muenchen : Deutsches Herzzentrum Muenchen
Dual Source CT Angiography for Detection of Coronary Artery Stenoses
Muenchen : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Munich : First Medizinische Klinik rechts der Isar
Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis
Munich : Kardiologische Praxis und Praxisklinik
Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis
Munich : Deutsches Herzzentrum Muenchen
Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis
Münster : Universitätsklinikum Münster, Klinik für Kardiologie
Clinical Performance of the Pantera Lux DCB Versus the Orsiro DES in Patients With "-Limus" DES-ISR.
Potsdam : EvB Klinkum
A Multinational Trial to Evaluate the Longterm Safety of the Parachute Implant System
Rhaunen : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Rostock : Universitat Rostok
A Multinational Trial to Evaluate the Longterm Safety of the Parachute Implant System
Rostock : Medical University Rostock
Comparison Between FFR Guided Revascularization Versus Conventional Strategy in Acute STEMI Patients With MVD.
Rostock : University of Rostock
Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery
Schmiedeberg : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Sulzbach-Rosenberg : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Trier : Krankenhaus Der Barmherzigen Brüder Trier
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Ulm : Universitätsklinikum Ulm
ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease
Ulm : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Villingen-Schwenningen : Innere Medizin III Kardiologie, Kliniken Villingen
Clinical Performance of the Pantera Lux DCB Versus the Orsiro DES in Patients With "-Limus" DES-ISR.
Wallerfing : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Weyhe-Leeste : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Witten : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Greece
Agia Varvara, Athens : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Alexandroupolis : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Athens : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Chalkida : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Ioannina :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
View More »
Ioannina : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Kallithea :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Magoula, Elefsina : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Patras : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Thessaloniki : Thessaloniki Heart Institute - St. Luke's Hospital
A Study of Hemopure® to Enhance Tissue Preservation During Cardiopulmonary Bypass Surgery
Thessaloniki : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Voula / Athens : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Hong Kong
Hong Kong :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Hong Kong : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Shatin, New Territories : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Shatin, New Territories,SAR :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Hungary
Berettyóújfalu : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Budapest :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Budapest : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Debrecen :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Komárom : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
View More »
Mosonmagyaróvár : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Sátoraljaújhely : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Székesfehérvár : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Szikszó : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Szolnok : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
India
Ahmedabad : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Bangalore : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Cochin : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Hyderabad : Ravi Bathina
Dual Source CT Angiography for Detection of Coronary Artery Stenoses
Jaipur : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
View More »
Lucknow, Utter Pradesh :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Mohali, Punjab :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Mysore : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
New Delhi :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
New Delhi : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Patiala : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Pune : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Saket,Delhi : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Vadodara : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Vijayawada : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Israel
Afula : HaEmek Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Ashkelon : Barzilai Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Beer Yahkov : Assaf Harofeh Medical Centre
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Haifa : Cardiovascular department, Carmel medical center
Monitoring and Characterization of Coronary Flow By Transthoracic Parametric Doppler (TPD) During Exercise Stress Test
Haifa : Bnai Zion Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
View More »
Haifa : Rambam Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Holon :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Holon : Edith Wolfson Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Jerusalem : Hadassah University Hospital
Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis
Jerusalem : Shaare Zedek Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Jerusalem : Hadassah Ein-Kerem Medical Centre
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Kfar Saba :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Kfar Saba : Meir Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Kfar Saba : Dr. Silber Clinic
The Diagnostic Benefits of the HyperQTM System in ECG Stress Testing
Nahariya : Western Galilee Hospital
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Ofakim :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Rehovot : Kaplan Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Rehovot : Kaplan Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Tel Aviv : Sourasky Medical Center
Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis
Tel Aviv : Tel Aviv Souraski Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Tel Hashomer : The Chaim Sheba Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Zafed : ZIV Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Zrifin : Assaf Harofeh Medical Center
Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis
Italy
Ascoli Piceno : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Asti : Cardinal Massaia Hospital
COMPETE: A Clinical Evaluation of Chrono Carbostent Carbofilm™ Coated Stent
Bari : Policlinico Universitario di Bari-Emodinamica Interventista
European Multicenter, Randomized, Comparative Efficacy/Safety Study of the Mar-Tyn TiN-Coated Stent
Bergamo : Cardiovascular Department Ospedali Riuniti di Bergamo
Optical Coherence Tomography for Drug Eluting Stent Safety
Bergamo : Cardiovascular Department Ospedali Riuniti di Bergamo
Optical Coherence Tomography for EVERolimus Eluting STent
View More »
Bergamo : Ospedali Riuniti di Bergamo
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Carpi : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Catania : Ferrarotto Hospital
REVEAL Study: Vessel Healing After Angioplasty
Chieti : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Cona (Ferrara) : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Cotignola : Maria Cecilia Hospital
COMPETE: A Clinical Evaluation of Chrono Carbostent Carbofilm™ Coated Stent
Cuneo : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Firenze : Azienda Ospedaliero-Universitaria Careggi
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Genova : Azienda Ospedaliera Universitaria San Martino
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Milano : Ospedale San Raffaele- Emodinamica e Cardiologia
European Multicenter, Randomized, Comparative Efficacy/Safety Study of the Mar-Tyn TiN-Coated Stent
Milano : Fondazione Centro S. Raffaele del Monte Tabor, Ospedale San Raffaele
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Milano : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Modena : University Hospital Modena
Optical Coherence Tomography (OCT) Evaluation of Re-endothelization: A Comparison of the Intrepide™ Stent Versus Taxus™
Napoli : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Novara : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Palermo :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Parma : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Pisa :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Pisa : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Ravenna : Ospedale di Ravenna, U.O. Cardiologia
European Multicenter, Randomized, Comparative Efficacy/Safety Study of the Mar-Tyn TiN-Coated Stent
Roma :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Roma : Campus Biomedico, Cardiologia
European Multicenter, Randomized, Comparative Efficacy/Safety Study of the Mar-Tyn TiN-Coated Stent
Roma : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Rome :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Sassari : Ospedale Civile SS Annunziata ASL 1
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Treviso : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Japan
Aichi : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Chiba : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Fukuoka : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Hokkaido : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Itabashi-ku : Nihon University Itabashi Hospital
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
View More »
Kagoshima : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Kamakura-shi : Shonan Kamakura General Hospital
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Kanagawa : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Kitakyushu-shi : Kokura Memorial Hospital
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Kurume-shi : Kurume University Hospital
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Kyoto : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Kyoto-shi : Kyoto University Hospital
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Minato-ku : The Cardiovascular Institute
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Nagano : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Nagasaki : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Oita : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Osaka : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Sakyo-ku : Kyoto University Hospital
ABSORB EXTEND Clinical Investigation
Shiga : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Shinagawa-ku : Showa University Hospital
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Shinjuku-ku : Department of Cardiology, Tokyo Women's Medical University
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Shizuoka : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Suita-shi : National Cerebral and Cardiovascular Center
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Tokyo : Teikyo University
ABSORB EXTEND Clinical Investigation
Tokyo : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Tokyo : Abbott Vascular Japan Co., Ltd.
XIENCE PRIME Everolimus Eluting Coronary Stent Post Marketing Surveillance (PMS) in Japan
Yokohama-shi : Saiseikai Yokohamashi Tobu Hospital
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Korea, Republic of
Busan : Inje university haeundae paik hospital
Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone
Busan : Kosin university gospel hospital
Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone
Busan : Pusan national university hospital
Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone
Cheongju : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Chunahn : Dankook University Hospital
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
View More »
Chungbuk : Chungbuk national university hospital
Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone
Daegu : Daegu Catholic University Medical Center
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Daegu : Dong-A University Medical Center
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Dae-Gu : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Daejeon : Chungnam National University Hospital
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Dongjak-Gu : Boramae Medical Center
Investigate Effect on Mean IMT of Probucol And/or CilosTazol in Patients With Coronary Heart dIsease Taking HMGCoA Reductase Inhibitor Therapy
Gangnam-gu, Seoul : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
GangNeung : GangNeung Asan Hospital
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Gwangju : Chonnam National University Hospital
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Gwangju : Chonnam National University Hospital
Effect of Fimasartan for Modification of Atheroma Vulnerability in DEFERred Coronary Disease (FIMA-DEFER)
Gwangju : Chonnam National University Hospital
Escitalopram in Depressive Patients With Acute Coronary Artery Syndrome
Gwangju : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Gyeonggi-do : Dongguk University Medical Center
Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone
Ilsan : National Health Insurance Corporation Ilsan Hospital
Registry to Evaluate the Efficacy of Zotarolimus-Eluting Stent
Incheon : Inha University Hospital
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Inchon : Inha University Hospital
Registry to Evaluate the Efficacy of Zotarolimus-Eluting Stent
Jeonju : Chonbuk National University Hospital
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
jeonju-si, Jeollabuk-Do : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Jinju : Gyeongsang National University Hospital
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Jongno-gu : Seoul National University Hospital
Investigate Effect on Mean IMT of Probucol And/or CilosTazol in Patients With Coronary Heart dIsease Taking HMGCoA Reductase Inhibitor Therapy
Seogu : Dong-A Medical Center
Investigate Effect on Mean IMT of Probucol And/or CilosTazol in Patients With Coronary Heart dIsease Taking HMGCoA Reductase Inhibitor Therapy
Seo-gu Busan : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Seongnam : Bundang CHA Hospital
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Seongnam-si : Seoul National University Bundang Hospital
Investigate Effect on Mean IMT of Probucol And/or CilosTazol in Patients With Coronary Heart dIsease Taking HMGCoA Reductase Inhibitor Therapy
Seongnam-si Gyeonggi-do : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Seoul :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Seoul : Hanyang National University Medical Center
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Seoul : Gangnam Severance Hospital
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Seoul : Asan Medical Center
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Seoul : Department of Medicine, Asan Medical Center University of Ulsan College of Medicine
Drug-Eluting Stenting Followed by Cilostazol tREAtment Reduces SErious Adverse Cardiac Events (DECREASE-PCI)
Seoul : Asan Medical Center
Effect of Fimasartan for Modification of Atheroma Vulnerability in DEFERred Coronary Disease (FIMA-DEFER)
Seoul : Seoul National University Hospital
Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTing Using the PRIME Platform (EXCELLENT-PRIME Registry)
Seoul : Asan Medical Center
Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and Safety
Seoul : 29 Centers
Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME)
Seoul : Seoul National University Hospital
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimen
Seoul : Samsung Medical Center
Investigate Effect on Mean IMT of Probucol And/or CilosTazol in Patients With Coronary Heart dIsease Taking HMGCoA Reductase Inhibitor Therapy
Seoul : 8 Locations
LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery)
Seoul : SNU Boramae Medical Center
Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone
Seoul : Seoul National University Hospital
Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone
Seoul : Seoul Boramae Hospital
Registry to Evaluate the Efficacy of Zotarolimus-Eluting Stent
Seoul : Seoul National University Hospital
Registry to Evaluate the Efficacy of Zotarolimus-Eluting Stent
Seoul : 26 Centers
The IRIS-Resolute Integrity (IRIS-Integrity)
Seoul : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Uijeongbu-si Kyonggi-do : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Ulsan : Ulsan University Hospital
Effect of Fimasartan for Modification of Atheroma Vulnerability in DEFERred Coronary Disease (FIMA-DEFER)
Latvia
Riga : Cardiology, Pauls Stradins Clinical University Hospital
Clinical Performance of the Pantera Lux DCB Versus the Orsiro DES in Patients With "-Limus" DES-ISR.
Lebanon
Beirut : Rafic Hariri University Hospital
Trial of Ateronon in Patients With Coronary Disease to Evaluate Its Effectiveness in Assessing the Risk Factors of Atherosclerosis
Malaysia
Kuala Lumpur :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Kuala Lumpur : Institute Jantung Negara
ABSORB EXTEND Clinical Investigation
Kuantan, Pahang :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Kubang Kerian :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Kuching : Sarawak General Hospital
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
View More »
Sarawak :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Mexico
Durango : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Mexico : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
México D.F, : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Monterrey : Cardiovascular Institute
Dual Source CT Angiography for Detection of Coronary Artery Stenoses
Monterrey NL : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Netherlands
Alkmaar :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Amsterdam :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Amsterdam : Onze Lieve Vrouwe Gasthuis Ziekenhuis
DELIVER Study: DELiverability of the Resolute Integrity Stent in All-Comer Vessels and Cross-OvER Stenting
Amsterdam : Academisch Medisch Centrum
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Amsterdam : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
View More »
Amsterdam : Academic Medical Center - University of Amsterdam
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
Beverwijk : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Den Haag : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Doetinchem : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Eindhoven : Catharina ZH Eindhoven
ABSORB EXTEND Clinical Investigation
Eindhoven : Catharina Ziekenhuis
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Eindhoven : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Enschede : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Goes : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Harderwijk : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Hoofddorp : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Leeuwarden : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Maastricht :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Maastricht : CARIM, Department of Cardiology
European Multicenter, Randomized, Comparative Efficacy/Safety Study of the Mar-Tyn TiN-Coated Stent
Nieuwegein : St Antonius Hospital
Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary Occlusions
Nijmegen :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Rotterdam : Maasstadhospital
Comparison Between FFR Guided Revascularization Versus Conventional Strategy in Acute STEMI Patients With MVD.
Rotterdam : Maasstad Ziekenhuis
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Rotterdam : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Rotterdam : Thorax Center - Erasmus MC
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
Sittard-geleen : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Sneek : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
The Hague : Medisch Centrum Haaglanden
Comparison Between FFR Guided Revascularization Versus Conventional Strategy in Acute STEMI Patients With MVD.
Tiel : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Tilburg : TweeSteden Ziekenhuis
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Utrecht :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Waalwijk :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
New Zealand
Auckland : Mercy Angiography Unit
ABSORB EXTEND Clinical Investigation
Auckland : Ascot Angiography
NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions
Auckland : Auckland City Hospital
NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions
Auckland : Mercy Angiography Unit, Ltd. Mercy Hospital
NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions
Auckland : North Shore Hospital
NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions
View More »
Christchurch :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Christchurch : Christchurch
NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions
Christchurch : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Dunedin : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Grafton, Auckland : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Hamilton : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Lower Hutt : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Nelson : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Otahuhu : Middlemore Hospital
NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions
Otahuhu, Auckland : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Palmerston North : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Takapuna, Auckland : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Tauranga : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Timaru : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Whangarei : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Norway
Bergen : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Bodo :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Moss : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Oslo :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Oslo : Oslo University Hospital
Comparison Between FFR Guided Revascularization Versus Conventional Strategy in Acute STEMI Patients With MVD.
View More »
Oslo : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Sandefjord :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Pakistan
Karachi : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Korangi / Karachi : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Lahore : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Multan : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Rawalpindi Cantt : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Peru
Callao : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Jesus Maria : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Lima : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Philippines
Ermita, Manila : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Manila : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Quezon City : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
San Juan : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Poland
Belchatów : American Heart of Poland S.A.
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Bialystok :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Bialystok : Novartis Investigative Site
Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients
Bielsko-Biala : American Heart of Poland S.A.
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Bydgoszcz : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
View More »
Chrzanów : American Heart of Poland S.A.
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Dabrowa Gornicza : Polsko-Amerykanskie Kliniki Serca III Oddzial Kardiologii Inwazyjnej, Angiologii i Elektrokardiologii
Prospective, Single-arm, Multicenter Study for Evaluation the Safety and Effectiveness of the ALEX Stent in a Real-world Setting of Percutaneous Coronary Interventions in Patients With Coronary Heart Disease
Dabrowa Górnicza : American Heart of Poland S.A.
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Gdansk :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Gdynia : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Katowice :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Katowice : SPZOZ, SPSK nr 7 Slaskiego Uniwersytetu Medycznego w Katowicach, Górnoslaskie Centrum Medyczne
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Kedzierzyn Kozle : American Heart of Poland S.A.
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Kowanowko : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Krakow :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Krakow : Carint Scanmed Szpital Sw. Rafala
Prospective, Single-arm, Multicenter Study for Evaluation the Safety and Effectiveness of the ALEX Stent in a Real-world Setting of Percutaneous Coronary Interventions in Patients With Coronary Heart Disease
Krakow : Szpital Uniwersytecki w Krakowie, Samodzielna Pracownia Zakladu Hemodynamiki i Angiografii
Prospective, Single-arm, Multicenter Study for Evaluation the Safety and Effectiveness of the ALEX Stent in a Real-world Setting of Percutaneous Coronary Interventions in Patients With Coronary Heart Disease
Krakow : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Kraków : Krakowski Szpital Specjalistyczny im. Jana Pawła II
Clinical Trial of the Edwards Aortic Bioprosthesis, Model 11000
Kraków : Szpital Uniwersytecki w Krakowie
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Kraków : Novartis Investigative Site
Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients
Lódz : Novartis Investigative Site
Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients
Mielec : American Heart of Poland S.A.
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Mielec : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Naleczow :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Ostrow Wielkopolski : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Plonsk : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Poznan :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Radom : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Ruda Slaska : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Siemianowice Slaskie : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Skierniewice : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Sopot :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Szczecin :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Torun : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Tychy : American Heart of Poland S.A.
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Tychy : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Ustron : Polsko-Amerykanskie Kliniki Serca I Oddzial Kardiologiczno-Angiologiczny
Prospective, Single-arm, Multicenter Study for Evaluation the Safety and Effectiveness of the ALEX Stent in a Real-world Setting of Percutaneous Coronary Interventions in Patients With Coronary Heart Disease
Warsaw : Instytut Kardiologii im. Prymasa Tysiąclecia Stefana Kardynała Wyszyńskiego
Clinical Trial of the Edwards Aortic Bioprosthesis, Model 11000
Warszawa :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Warszawa : Centralny Szpital Kliniczny MSWiA w Warszawie Klinika Kardiologii Inwazyjnej
Prospective, Single-arm, Multicenter Study for Evaluation the Safety and Effectiveness of the ALEX Stent in a Real-world Setting of Percutaneous Coronary Interventions in Patients With Coronary Heart Disease
Warszawa : Centralny Szpital Kliniczny Ministerstwa Spraw Wewnetrznych i Administracji w Warszawie
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Warszawa : Instytut Kardiologii
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Warszawa : Novartis Investigative Site
Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients
Warszawa : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Wloclawek : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Wroclaw :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Wroclaw : 4th Wojskowy Szpital Kliniczny z Poliklinika, Klinika Kardiologii
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Wroclaw : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Puerto Rico
Guaynabo : San Patricio MEDFLIX (San Patricio MRI & CT Center)
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Rio Piedras : Transcatheter Medical, Inc. Centro Cardiovascular de Caguas y del Caribe
PRE-DETERMINE Cohort Study
San Juan : VA Caribbean Healthcare System
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Romania
Bucharest : Cardiovascular Diseases Institute CC Iliescu
BIOFLOW-III Romania Satellite Registry
Bucharest : University Hospital Bucharest
BIOFLOW-III Romania Satellite Registry
Bucharest : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Cluj Napoca : County Emergency Hospital
BIOFLOW-III Romania Satellite Registry
Deva : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
View More »
Galati : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Targu Mures : Country Hospital
BIOFLOW-III Romania Satellite Registry
Targu Mures : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Russian Federation
Barnaul :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Barnaul : Altai Regional Cardiological Dispensary
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Chelyabinsk : Regional Clinical Hospital №3
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Ekaterinburg : Ural Institute of Cardiology
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Ekaterinburg : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
View More »
Ivanovo : Cardiological Dispensary
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Kazan : Republic Clinical Hospital № 2
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Kemerovo :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Kemerovo : State Research Institute for Complex Issues of Cardiovascular Diseases
Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI
Kemerovo : Research Institute for Complex Issues of Cardiovascular Diseases
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Kemerovo : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Kirovsk, Leningradskaya Region : Medical Center "Alliance"
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Krasnoyarsk : Regional Clinical Hospital
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Moscow :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Moscow : Municipal Hospital #15
Efficacy and Safety of Ad5FGF-4 for Myocardial Ischemia in Patients With Stable Angina Due to Coronary Artery Disease
Moscow : University Clinical Hospital #1
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Moscow : National Research Center For Preventive Medicine
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Moscow : City Clinical Hospital #15 named after O.M. Filatov
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Moscow : City Clinical Hospital n.a. S.P.Botkin
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Moscow : "City Clinical Hospital # 23 n.a.
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Moscow : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Nizhni Novgorod : City Clinical Hospital #5
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Novosibirsk :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Novosibirsk : City Clinical Emergency Hospital # 2
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Novosibirsk : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Penza : Penza Regional Clinical Hospital n.a. N.N. Burdenko
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Petrozavodsk :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Ryazan :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Ryazan : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
S.-Petresburg : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Saint Petersburg :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Saint-Petersburg : Federal Center of Heart, Blood and Endocrinology n.a. V.A.Almazov
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
St Pertersburg : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
St. Petersburg :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
St'Petersburg : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
St-Petersburg : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Tomsk :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Tomsk : Scientific and Research Institution Of Cardiology
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Volgograd : Volgograd Regional Clinical Cardiological Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Yaroslavl :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Yekaterinburg : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Singapore
Slovakia
Bratislava : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Kosice : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Nitra : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
South Africa
Bellville : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Bloemfontein : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Cape Town :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Johannesburg : Milpark Hospital
A Study of Hemopure® to Enhance Tissue Preservation During Cardiopulmonary Bypass Surgery
Johannesburg : Sunninghill Hospital
ABSORB EXTEND Clinical Investigation
View More »
Kempton Park : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Kuils River : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Lynnwood Ridge, Pretoria : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Olivedale : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Paarl : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Parktown : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Parktown West : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Parow : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Parow, Cape Town :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Pinelands : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Pretoria :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Somerset West : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Soweto : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Umhlanga : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Spain
Alicante : Hospital General Universitario de Alicante
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Alicante : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Barcelona : Hospital Vall d´Hebrón
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Barcelona : Hospital Clinic I Provincial de Barcelona
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Barcelona : Hospital Trías i Pujol
The 001-DIOR Multicenter Registry
View More »
Barcelona : Hospital del Mar
The 001-DIOR Multicenter Registry
Barcelona : Hospital Sant Pau
The 001-DIOR Multicenter Registry
Granada : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Jerez de la Frontera : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
L´Hospitalet de Llobregat : Hospital Universitario de Bellvitge
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Madrid :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Madrid : La Paz
ABSORB EXTEND Clinical Investigation
Madrid : Hospital Universitario La Paz
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Madrid : Hospital Clínico San Carlos
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Madrid : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Malaga : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Marid : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Oviedo : Hospital Central de Asturias
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Oviedo : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Pozuelo de Alarcón/Madrid : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
San Juan (Alicante) : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
San Sebastián : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
San Sebastián de los Reyes/Madrid : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Santander : Hospital Universitario Marques de Valdecilla
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Santander : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Sevilla : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Sta Coloma de Gramanet (Barcelona) : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Valdemoro/Madrid : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Vigo : Complejo Hospitalario Universitario de Vigo, Meixoeiro Hospital
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Sweden
Eksjö : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Falun : Falu lasarett
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Goteborg : Sahlgrenska Götheborg University Hospital
Comparison Between FFR Guided Revascularization Versus Conventional Strategy in Acute STEMI Patients With MVD.
Göteborg : Sahlgrenska Universitetsjukhuset
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Göteborg : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
View More »
Karlstad : Centralsjukhuset i Karlstad
BIOFLOW-III Sweden Satellite Registry
Karlstad : Karlstad Central Hospital
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Linköping : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Lund : Lund University Hospital
ABSORB EXTEND Clinical Investigation
Lund : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Malmö : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Oerebro : Kardiologiska Kliniken
BIOFLOW-III Sweden Satellite Registry
Örebro : Universitetssjukhuset Örebro
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Östersund : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Stockholm :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Stockholm : Danderyd University Hospital
BIOFLOW-III Sweden Satellite Registry
Stockholm : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Umeå : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Uppsala : Akademiska Sjukhuset i Uppsala
BIOFLOW-III Sweden Satellite Registry
Uppsala : Uppsala University Hospital
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Uppsala : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Västerås : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Västervik : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Switzerland
Aarau : Kantonsspital Aarau
Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents
Basel : Universitätsklinik Basel
Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents
Basel : University Hospital
The eSVS® Mesh Post-Marketing Trial
Bern : Department of Cardiology, Bern University Hospital
Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents
Freiburg : HFR Freiburg
Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents
View More »
Genève : Hôpitaux Universitaires de Genève
Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents
Lausanne : Service de cardiologie CHUV
Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents
Lugano : Cardiocentro Ticino, Cardiologia
European Multicenter, Randomized, Comparative Efficacy/Safety Study of the Mar-Tyn TiN-Coated Stent
Luzern : Luzerner Kantonsspital
Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents
Meyrin : Hôpital de la Tour
A Randomized Clinical Evaluation of the BioFreedom™ Stent
St. Gallen : Kantonsspital St. Gallen
Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents
Zurich : Unversitats Spital Zurich
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Zürich : Stadtspital Triemli
Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents
Taiwan
Changhua : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
New Taipei City :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Niao-Sung Hsiang : Chang Gung Memorial Hospital
ABSORB EXTEND Clinical Investigation
Taichung : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Tainan : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
View More »
Taipei :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Taipei : National Taiwan University Hospital
ABSORB EXTEND Clinical Investigation
Taipei : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Taipei City : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Thailand
Bangkok : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Chiangmai : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Tunisia
Monastir : cardiology department, hospital Fattouma Bourguiba
Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Body Mass Index ≥ 27
Ukraine
Donetsk : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Kharkiv : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Kharkiv City :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Kiev :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Kyiv :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
View More »
Kyiv : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Kyiv City :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Lviv : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Odesa :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Odesa : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Odessa :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Vinnytsia : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Zaporizhzhia : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
United Kingdom
Barnet : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Birmingham :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Brighton : Sussex Cardiac Centre
European Bifurcation Club Trial - Two-stent Versus One-stent Technique for Large Bifurcation Lesions
Brighton : Royal Sussex County Hospital
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Cambridge : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
View More »
Cardiff :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Chelsea : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Chertsey : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Chichester : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Coatbridge : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Cottingham : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Cumbernauld : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Glasgow : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Hamilton : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Harrow : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Headington : Oxford Heart Centre - John Radcliffe Hospital
A Study of Hemopure® to Enhance Tissue Preservation During Cardiopulmonary Bypass Surgery
Hertfordshire : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Liverpool :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Liverpool : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Liverpool : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
London :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
London : King's College
MR INFORM - MR Perfusion Imaging to Guide Management of Patients With Stable Coronary Artery Disease
London : University College Hospital London NHS Foundation Trust
Rubidium-82 PET and Tc-99m-MIBI SPET: A Head to Head Comparison
Manchester :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Middlesbrough : The James Cook University Hospital
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Motherwell : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Newcastle Upon Tyne : Freeman Hospital
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Newcastle-upon-Tyne : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Oldham :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Oxford :
A Study to Evaluate the Effect of Aleglitazar on Cardiac Energetics and Function in Patients With Type 2 Diabetes Mellitus and no History of Coronary Artery Disease
Oxford : Department of Cardiovascular Medicine, University of Oxford
Effect of 6R-BH4 Treatment in Coronary Artery Disease (OXBIO Study)
Paisley : GSK Investigational Site
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Surrey : Ashford and Saint Peter's Hospital NHS Trust
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
West Bromwich, West Midlands :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
West Sussex : Saint Richards Hospital
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
